Kidney function gets its own row, since reduced GFR raises hyperkalemia risk substantially
You dont need to be obese to start a GLP-1. In practice, though, you doat least according to the US Food and Drug Administration, which has only approved GLP-1 drugs for people with clinical obesity or Type 2 diabetes and for people who are overweight with weight-related comorbidities
Paschou, E
The onset of T2DM is closely related to the presence of obesity in PWS, the latter related to an insufficient and delayed satiety response, due to uncontrolled food intake mechanisms caused by a hypothalamic dysfunction (192)
Other examples of such social goods are roads, infrastructure, ports, public schools, law enforcement, defense, clean air, clean water, healthcare, and literacy